L-MIND: Safety and efficacy of tafasitamab in patients with relapsed/refractory diffuse large B-cell lymphoma on treatment for at least 2 years Meeting Abstract
| Authors: | Duell, J.; Jurczak, W.; Liberati, A. M.; Halka, J.; Carbó, E. P.; Abrisqueta, P.; Maddocks, K. J.; Dreyling, M.; Rosenwald, A.; Bakuli, A.; Amin, A.; Gurbanov, K.; Salles, G. |
| Abstract Title: | L-MIND: Safety and efficacy of tafasitamab in patients with relapsed/refractory diffuse large B-cell lymphoma on treatment for at least 2 years |
| Meeting Title: | 10th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | lenalidomide; phase ii; dlbcl; abcl; tafasitamab; l-mind |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 22 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Sep 28-Oct 1 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-10-01 |
| Start Page: | S375 |
| Language: | English |
| ACCESSION: | WOS:000897948100412 |
| PROVIDER: | wos |
| DOI: | 10.1016/s2152-2650(22)01533-6 |
| Notes: | Meeting Abstract: ABCL-388 -- Source: Wos |
